Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script
Frontiers in Bioscience-Landmark · 2026-05-21 · 31 (5)
DOI: 10.31083/fbl52945 ↗At a glance
Editorial in Frontiers in Bioscience-Landmark, published online on 2026-05-21. Written by Ralf Weiskirchen. Institution: Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aache…. 20 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.
Cite
APA
Weiskirchen, R. (2026). Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark, 31(5). https://doi.org/10.31083/fbl52945
Vancouver
Weiskirchen R. Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark. 2026;31(5). doi:10.31083/fbl52945
BibTeX
@article{Weiskirchen2026,
author = {Weiskirchen, Ralf},
title = {Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {5},
doi = {10.31083/fbl52945}
}
EUVIMED